|
14 Feb 2026 |
Infosys
|
Consensus Share Price Target
|
1369.10 |
1820.45 |
- |
32.97 |
buy
|
|
|
|
|
21 Jan 2026
|
Infosys
|
Geojit BNP Paribas
|
1369.10
|
1861.00
|
1654.40
(-17.24%)
|
35.93 |
Buy
|
|
|
Infosys delivered robust financial results in Q3FY26, reflecting resilient demand and effective execution across key business verticals. The quarter saw notable developments, including robust deal wins, strategic artificial intelligence (AI) partnerships and successful execution of its largest-ever buyback. The company benefited from strong momentum in AI adoption, improved employee retention and continued expansion in core business segments. The management's focus on upskilling and talent retention further strengthened its position. Consistent success in securing significant fresh deals has enabled the company to steadily expand its...
|
|
19 Jan 2026
|
Infosys
|
IDBI Capital
|
1369.10
|
1714.00
|
1681.20
(-18.56%)
|
Target met |
Hold
|
|
|
The company's Q3FY26 performance highlighted disciplined execution amid macro uncertainty, with sustained CC growth and FY26 revenue guidance upgraded to 33.5%, reflecting recovery in discretionary spending. Large-deal momentum remains robust at USD 4.8bn with 57% net-new, indicates a strong demand visibility, particularly in financial services where Infosys is a preferred AI partner for 15 of the top 25 banking clients. The company has firmly positioned itself at the forefront of enterprise AI monetization, engaging 90% of its top-200 clients across 4.6k AI projects, supported by its differentiated Topaz and Fabric platforms coupled with...
|
|
16 Jan 2026
|
Infosys
|
ICICI Direct
|
1369.10
|
1710.00
|
1689.80
(-18.98%)
|
Target met |
Hold
|
|
|
Strong deal momentum improves medium-term visibility: Infosys' strong large-deal performance in Q3, with large-deal TCV of US$4.8 bn (57% net new across 26 deals), improves revenue visibility into FY27. The traction reflects rising client confidence in Infosys' enterprise AI capabilities (Topaz), particularly in Financial Services (+3.9% YoY CC) and EURS (+0.5% YoY CC), where management expects growth acceleration in FY27 vs FY26. Manufacturing and Retail/CPG, however, remain under pressure, implying that deal wins may translate into revenue gradually rather than immediately. Backed by strong YTD...
|
|
16 Jan 2026
|
Infosys
|
Axis Direct
|
1369.10
|
1820.00
|
1689.80
(-18.98%)
|
32.93 |
Buy
|
|
|
We maintain BUY rating on the stock.
|
|
15 Jan 2026
|
Infosys
|
Anand Rathi
|
1369.10
|
1884.00
|
1599.80
(-14.42%)
|
37.61 |
Buy
|
|
|
Infosys delivered a resilient performance in a seasonally softer quarter with 0.6% q/q cc revenue growth and a large deal TCV of $4.8bn (up 92% y/y), aided by ~$1.6bn NHS deal.
|
|
15 Jan 2026
|
Infosys
|
BOB Capital Markets Ltd.
|
1369.10
|
1791.00
|
1599.80
(-14.42%)
|
30.82 |
Hold
|
|
|
3Q revenue beats estimate on quick ramp-up of recently won large deal - NHS UK (life sciences) and those in Financial Services
|
|
15 Jan 2026
|
Infosys
|
ICICI Securities Limited
|
1369.10
|
1630.00
|
1599.80
(-14.42%)
|
Target met |
Hold
|
|
|
Infosys reported a marginal beat on revenue and tad miss on margins (excluding 40bps one-off benefit from sale of property) vs. our and consensus expectations in Q3FY26.
|
|
15 Jan 2026
|
Infosys
|
Emkay
|
1369.10
|
1750.00
|
1599.80
(-14.42%)
|
27.82 |
Buy
|
|
|
Infosys delivered a mixed operating performance in Q3, with beat on revenue estimates albeit margin missing expectations. Revenue grew 0.6% CC QoQ. Adjusted EBITM declined by 20bps QoQ to 20.8%, missing our estimate.
|
|
15 Jan 2026
|
Infosys
|
Deven Choksey
|
1369.10
|
1852.00
|
1599.80
(-14.42%)
|
35.27 |
Buy
|
|
|
Infosys raised its FY26 CC revenue growth guidance to 3–3.5% while maintaining a 20–22% margin band, reflecting modest growth amid H2 seasonality and macro caution.
|
|
14 Jan 2026
|
Infosys
|
Motilal Oswal
|
1369.10
|
2200.00
|
1599.80
(-14.42%)
|
60.69 |
Buy
|
|
|
Infosys (INFO) reported 3QFY26 revenue of USD5.1b, up 0.6% QoQ in CC/1.7% YoY in CC vs. our estimate of 0.3% QoQ in CC. Adj. EBIT margin stood at 21.2%, in line with our estimate of 21.1%. Adj. EBIT rose 3.1% QoQ/8.2% YoY to INR 96b (est. INR95b). Adj. PAT came in at INR76b, up 3.5% QoQ/12.0% YoY, above our estimate of INR73b.
|
|
09 Jan 2026
|
Infosys
|
Motilal Oswal
|
1369.10
|
2150.00
|
1614.10
(-15.18%)
|
57.04 |
Buy
|
|
|
We have argued in our recent upgrade note (Time to buy the next cycle, 24th Nov 2025) that 2026 will be the year when enterprises start deploying AI at scale, and Indian IT services stand to benefit from this.
|
|
28 Oct 2025
|
Infosys
|
Geojit BNP Paribas
|
1369.10
|
1712.00
|
1500.20
(-8.74%)
|
Target met |
Buy
|
|
|
Infosys delivered a steady performance driven by resilience in deal execution, continued traction in digital transformation projects and operational discipline across key verticals. Its focus on GenAI adoption, platform monetisation and cloud-led modernisation is expected to enhance scalability and differentiation. Strategic acquisitions in cybersecurity and consulting strengthen domain capabilities and regional presence, while internal efficiency initiatives and talent upskilling support...
|
|
17 Oct 2025
|
Infosys
|
Emkay
|
1369.10
|
1650.00
|
1441.10
(-5.00%)
|
Target met |
Buy
|
|
|
Infosys delivered an in-line operating performance in Q2. Revenue grew 2.2% CC QoQ, aided by ~20bps contribution from M&As and improved realizations from Project Maximus amid soft volumes.
|
|
17 Oct 2025
|
Infosys
|
Axis Direct
|
1369.10
|
1620.00
|
1441.10
(-5.00%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock.
|
|
17 Oct 2025
|
Infosys
|
Motilal Oswal
|
1369.10
|
1650.00
|
1441.10
(-5.00%)
|
Target met |
Neutral
|
|
|
Infosys (INFO) reported 2QFY26 revenue of USD5.0b, up 2.2% QoQ in CC/2.9% YoY in CC vs. our estimate of 2.4% QoQ in CC. EBIT margin stood at 21.0% vs. our estimate of 21.2%.
|
|
17 Oct 2025
|
Infosys
|
IDBI Capital
|
1369.10
|
1714.00
|
1441.10
(-5.00%)
|
Target met |
Buy
|
|
|
Infosys reported a steady but cautious performance in Q2FY26, showcasing strong execution despite a weak demand environment. Revenue rose 2.2% sequentially and 2.9%YoY in CC term, crossing USD 5bn. Operating margin improved to 21%, supported by better efficiency under Project Maximus and stronger pricing. The company secured USD 3.1bn in large deals (67% net new) and announced an additional USD 1.6bn megadeal after the quarter, reflecting continued client trust. Free cash flow was healthy at USD 1.1bn, equal to 131% of net profit, while attrition dropped to 14.3%. Infosys continued advancing its...
|
|
17 Oct 2025
|
Infosys
|
BOB Capital Markets Ltd.
|
1369.10
|
1584.00
|
1441.10
(-5.00%)
|
Target met |
Hold
|
|
|
Better than estimated 2QFY26. Realization driven. Lower end of revenue guidance raised by 100bps. Points to normal seasonality in 2H
|
|
17 Oct 2025
|
Infosys
|
Deven Choksey
|
1369.10
|
1770.00
|
1471.50
(-6.96%)
|
29.28 |
Buy
|
|
|
Infosys raised its FY26 CC revenue growth guidance to 2–3% while maintaining a 20–22% margin band, reflecting modest growth amid H2 seasonality and macro caution.
|
|
17 Oct 2025
|
Infosys
|
ICICI Direct
|
1369.10
|
1550.00
|
1441.10
(-5.00%)
|
Target met |
Hold
|
|
|
Decent quarter; Guidance points to muted H2 About the stock: Infosys is one of the leading IT players catering to BFSI, Retail, Strategic AI and cloud focus positions for future upside: Infosys continues to advance its AI-led transformation with 2,500+ AI projects, 250 agentic AI initiatives, and deep partnerships across the AI value chain. Proprietary...
|
|
12 Sep 2025
|
Infosys
|
Deven Choksey
|
1369.10
|
1830.00
|
1509.70
(-9.31%)
|
33.66 |
Buy
|
|
|
Infosys’ Board approved a buyback of equity shares worth INR 180bn at INR 1,800 per share, representing up to 100 Mn. shares (~2.4% of paid-up capital)
|